Asymptomatic norovirus infections in nicaraguan children and its association with viral properties and histo-blood group antigens

Pediatric Infectious Disease Journal

Volumn 29, Issue 10, 2010, Pages 934-939

  Bucardo, Filemon ^a,b,c   Nordgren, Johan ^b   Carlsson, Beatrice ^b   Kindberg, Elin ^b,d   Paniagua, Margarita ^a   Möllby, Roland ^c   Svensson, Lennart ^b  

^a UNIVERSITY OF LEÓN   (Spain)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d National Board of Forensic Medicine   (Sweden)

Author keywords

asymptomatic; host genetic factors; norovirus

Indexed keywords

BLOOD GROUP A ANTIGEN;

ARTICLE; BLOOD GROUP AB; CHILD; CLINICAL ARTICLE; DIARRHEA; FEMALE; HUMAN; MALE; NICARAGUA; NOROVIRUS INFECTION; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS INFECTION; VIRUS STRAIN;

EID: 77957280694     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181ed9f2f     Document Type: Article

References (50)

1. Zheng DP, Ando T, Fankhauser RL, et al. Norovirus classification and proposed strain nomenclature. Virology. 2006;346:312-323. (Pubitemid 43357875)
2. Siebenga JJ, Vennema H, Zheng DP, et al. Norovirus illness is a global problem: emergence and spread of norovirus GII. 4 variants, 2001-2007. J Infect Dis. 2009;200:802-812.
3. Bull RA, Tu ET, McIver CJ, et al. Emergence of a new norovirus genotype II 4 variant associated with global outbreaks of gastroenteritis. J Clin Microbiol. 2006;44:327-333.
4. Gallimore CI, Iturriza-Gomara M, Xerry J, et al. Inter-seasonal diversity of norovirus genotypes: emergence and selection of virus variants. Arch Virol. 2007;152:1295-1303. (Pubitemid 47024693)
5. Lopman B, Vennema H, Kohli E, et al. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet. 2004;363:682-688. (Pubitemid 38296554)
6. Patel MM, Widdowson MA, Glass RI, et al. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis. 2008;14: 1224-1231.
7. Lindesmith L, Moe C, Marionneau S, et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med. 2003;9:548-553. (Pubitemid 36597100)
8. Kindberg E, Akerlind B, Johnsen C, et al. Host genetic resistance to symptomatic norovirus (GGII.4) infections in Denmark. J Clin Microbiol. 2007;45:2720-2722. (Pubitemid 47295514)
9. Thorven M, Grahn A, Hedlund KO, et al. A homozygous nonsense mutation (428G-A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol. 2005;79:15351-15355.
10. Carlsson B, Kindberg E, Buesa J, et al. The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII. 4 Norovirus infection. PloS One. 2009;4:e5593.
11. Kindberg E, Svensson L. Genetic basis of host resistance to norovirus infection. Future Virol. 2009;4:369-382.
12. Bucardo F, Kindberg E, Paniagua M, et al. Genetic susceptibility to symptomatic norovirus infection in Nicaragua. J Med Virol. 2009;81:728-735.
13. Tan M, Jin M, Xie H, et al. Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol. 2008;80:1296-1301. (Pubitemid 351706011)
14. Hutson AM, Airaud F, LePendu J, et al. Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol. 2005;77:116-120. (Pubitemid 41076487)
15. Johnson PC, Mathewson JJ, DuPont HL, et al. Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis. 1990;161:18-21.
16. Parrino TA, Schreiber DS, Trier JS, et al. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med. 1977;297:86-89.
17. Graham DY, Jiang X, Tanaka T, et al. Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis. 1994;170:34-43. (Pubitemid 24186422)
18. Gallimore CI, Cubitt D, du Plessis N, et al. Asymptomatic and symptomatic excretion of noroviruses during a hospital outbreak of gastroenteritis. J Clin Microbiol. 2004;42:2271-2274. (Pubitemid 38637863)
19. Ozawa K, Oka T, Takeda N, et al. Norovirus infections in symptomatic and asymptomatic food handlers in Japan. J Clin Microbiol. 2007;45:3996-4005. (Pubitemid 350274883)
20. Garcia C, DuPont HL, Long KZ, et al. Asymptomatic norovirus infection in Mexican children. J Clin Microbiol. 2006;44:2997-3000. (Pubitemid 44228604)
21. Monica B, Ramani S, Banerjee I, et al. Human caliciviruses in symptomatic and asymptomatic infections in children in Vellore, South India. J Med Virol. 2007;79:544-551. (Pubitemid 46564353)
22. O'Ryan ML, Lucero Y, Prado V, et al. Symptomatic and asymptomatic rotavirus and norovirus infections during infancy in a Chilean birth cohort. Pediatr Infect Dis J. 2009;28:879-884.
23. Zintz C, Bok K, Parada E, et al. Prevalence and genetic characterization of caliciviruses among children hospitalized for acute gastroenteritis in the United States. Infect Genet Evol. 2005;5:281-290. (Pubitemid 40298337)
24. Nordgren J, Bucardo F, Dienus O, et al. Novel light-upon-extension real-time PCR assays for detection and quantification of genogroup I and II noroviruses in clinical specimens. J Clin Microbiol. 2008;46:164-170.
25. Kojima S, Kageyama T, Fukushi S, et al. Genogroup-specific PCR primers for detection of Norwalk-like viruses. J Virol Methods. 2002;100:107-114. (Pubitemid 34003629)
26. Bucardo F, Nordgren J, Carlsson B, et al. Pediatric norovirus diarrhea in Nicaragua. J Clin Microbiol. 2008;46:2573-2580.
27. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4:406-425.
28. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980;16:111-120. (Pubitemid 11166431)
29. Katayama K, Shirato-Horikoshi H, Kojima S, et al. Phylogenetic analysis of the complete genome of 18 Norwalk-like viruses. Virology. 2002;299:225-239. (Pubitemid 35356599)
30. Kageyama T, Shinohara M, Uchida K, et al. Coexistence of multiple genotypes, including newly identified genotypes, in outbreaks of gastroenteritis due to Norovirus in Japan. J Clin Microbiol. 2004;42:2988-2995. (Pubitemid 38938047)
31. Rockx B, De Wit M, Vennema H, et al. Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis. 2002;35:246-253. (Pubitemid 34800271)
32. Amar CF, East CL, Gray J, et al. Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993-1996). Eur J Clin Microbiol Infect Dis. 2007;26:311-323. (Pubitemid 46716797)
33. Jiang X, Huang P, Zhong W, et al. Human milk contains elements that block binding of noroviruses to human histo-blood group antigens in saliva. J Infect Dis. 2004;190:1850-1859. (Pubitemid 39487832)
34. Makita K, Hayakawa Y, Okame M, et al. First detection of IgA against norovirus in breast milk. Clin Lab. 2007;53:125-128. (Pubitemid 46656565)
35. Morrow AL, Ruiz-Palacios GM, Jiang X, et al. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr. 2005;135:1304-1307. (Pubitemid 40638353)
36. Atmar RL, Opekun AR, Gilger MA, et al. Norwalk virus shedding after experimental human infection. Emerg Infect Dis. 2008;14:1553-1557.
37. Gentry J, Vinje J, Guadagnoli D, et al. Norovirus distribution within an estuarine environment. Appl Environ Microbiol. 2009;75:5474-5480.
38. Nordgren J, Matussek A, Mattsson A, et al. Prevalence of norovirus and factors influencing virus concentrations during one year in a full-scale wastewater treatment plant. Water Res. 2009;43:1117-1125.
39. Donaldson EF, Lindesmith LC, Lobue AD, et al. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Immunol Rev. 2008;225:190-211.
40. Widdowson MA, Cramer EH, Hadley L, et al. Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus-United States, 2002. J Infect Dis. 2004; 190:27-36. (Pubitemid 38858401)
41. Tu ET, Bull RA, Greening GE, et al. Epidemics of gastroenteritis during 2006 were associated with the spread of norovirus GII.4 variants 2006a and 2006b. Clin Infect Dis. 2008;46:413-420.
42. Okabayashi T, Yokota S, Ohkoshi Y, et al. Occurrence of norovirus infections unrelated to norovirus outbreaks in an asymptomatic food handler population. J Clin Microbiol. 2008;46:1985-1988. (Pubitemid 351831831)
43. Barreira DM, Ferreira MS, Fumian TM, et al. Viral load and genotypes of noroviruses in symptomatic and asymptomatic children in Southeastern Brazil. J Clin Virol. 2010;47:60-64.
44. Gallimore CI, Green J, Lewis D, et al. Diversity of noroviruses cocirculating in the north of England from 1998 to 2001. J Clin Microbiol. 2004;42: 1396-1401. (Pubitemid 38500771)
45. Murata T, Katsushima N, Mizuta K, et al. Prolonged norovirus shedding in infants 6 months of age with gastroenteritis. Pediatr Infect Dis J. 2007;26:46-49.
46. Nilsson M, Hedlund KO, Thorhagen M, et al. Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype. J Virol. 2003;77:13117-13124. (Pubitemid 37494307)
47. Kirkwood CD, Streitberg R. Calicivirus shedding in children after recovery from diarrhoeal disease. J Clin Virol. 2008;43:346-348.
48. Ludwig A, Adams O, Laws HJ, et al. Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus. J Med Virol. 2008;80:1461-1467. (Pubitemid 351897420)
49. Siebenga JJ, Beersma MF, Vennema H, et al. High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution. J Infect Dis. 2008;198:994-1001.
50. Westhoff TH, Vergoulidou M, Loddenkemper C, et al. Chronic norovirus infection in renal transplant recipients. Nephrol Dial Transplant. 2009;24: 1051-1053.